Leukemia Research
Volume 36, Issue 5 , Pages 607-618 , May 2012

Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine

Received 5 August 2011 ,Revised 28 October 2011 ,Accepted 29 November 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(11)00577-7

doi: 10.1016/j.leukres.2011.11.024

Leukemia Research
Volume 36, Issue 5 , Pages 607-618 , May 2012